Home > Animal Health & Nutrition > Veterinary Medical Devices > Veterinary Molecular Diagnostics Market

Veterinary Molecular Diagnostics Market Analysis

  • Report ID: GMI6325
  • Published Date: Jul 2023
  • Report Format: PDF

Veterinary Molecular Diagnostics Market Analysis

Based on products, the veterinary molecular diagnostics market is segmented into kits & reagents and instruments. The kits & reagents segment held highest market share and was valued at USD 209 million in 2022. The adoption of kits & reagents is increasing all over the globe with the increasing demand of infectious disease diagnostic testing in companion and livestock animals. Also, there is a growing demand for ready-to-use diagnostic kits and reagents that offer convenience and ease of use for veterinarians. These kits eliminate the need for extensive laboratory infrastructure and specialized expertise, making them more accessible in various healthcare settings. Kits and reagents are user-friendly, which makes them a more convenient option for veterinarians and other healthcare professionals.
 

Based on technology, the global veterinary molecular diagnostics market is categorized into PCR, DNA sequencing, microarray, and INAAT kits. PCR segment is further sub-categorized into real-time PCR and other PCRs. In 2022, the PCR segment is expected to witness considerable growth at CAGR of 8.9% by 2032. It is because PCR technology has been proven to be the most reliable and fastest technique to diagnose the cause of diseases. PCR offers high sensitivity, specificity, and rapid results, making it a valuable tool for the detection and monitoring of various infectious diseases in animals.
 

Based on application, the veterinary molecular diagnostics market is segmented into infectious, genetic, and other applications. The infectious diseases segment is sub-segmented into bacterial, viral, parasitic, and other infectious diseases. The infectious disease segment is expected to reach USD 362.3 million by 2032. The rising prevalence of infectious diseases in animals is high, driving the demand for accurate and timely diagnostics to identify and treat such diseases. Due to the high emphasis on public health and animal health, there is a high demand for the early detection and control of zoonotic diseases.
 

Veterinary Molecular Diagnostics Market Share, By Animal Type (2022)

Based on animal type, the veterinary molecular diagnostics market is divided into companion and livestock animals. The companion animals’ segment is sub-divided into dogs, cats, horses, and other companion animals, whereas the livestock animals segment is sub-divided into cattle, swine, poultry, and other livestock animals. The companion animal segment held largest market share of 63.8% in 2022 attributed to factors such as rising adoption of companion animals like dogs and cats in the countries, rising focus on pet health, increasing adoption of pet insurance and animal healthcare expenditure. The growing humanization of pets is leading to increasing number of pet owners taking their pets to veterinarians for regular check-ups, vaccination or for identifying the health status of their pets in order to maintain the overall health.
 

Based on end-user, the veterinary molecular diagnostics market is classified into diagnostic laboratories, veterinary clinics, veterinary hospitals, and other end-users. Diagnostic laboratories segment is expected grow at CAGR of 8.6% by 2032. Veterinary diagnostic laboratories have specialized expertise, skilled personnel, and well-equipped facilities for performing molecular diagnostics. Such laboratories have well-developed infrastructure, including advanced laboratory devices which improves the handling of complex diagnostic procedures effectively and precisely. It offers a wide range of molecular tests for diagnosing various infectious diseases, genetic conditions, and immune-related disorders in animals.
 

U.S. Veterinary Molecular Diagnostics Market Size, 2020- 2032(USD Million)

North America veterinary molecular diagnostics market is expected to grow at CAGR of 8.1% by 2032. North America has well-developed veterinary healthcare infrastructure, including veterinary hospitals, clinics, and specialized veterinary centers. The presence of skilled veterinarians, advanced veterinary diagnostic equipment and techniques, and a wide range of treatments and veterinary services.
 

The U.S. is one of the countries which has the largest pet populations in the world, with a significant number of households owning pets. In U.S., dogs and cats are the most common pets, but there is also a considerable population of birds, fish, small mammals, and reptiles.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size for veterinary molecular diagnostics was USD 298 million in 2022 and is anticipated to reach USD 678.8 million by 2032 owing to the increasing adoption of companion animals along with the high prevalence of zoonotic and foodborne diseases

The kits & reagents segment generated USD 209 million in revenue in 2022 and is expected to gain significant momentum through 2032 owing to increasing demand of infectious disease diagnostic testing in companion and livestock animals.

North America market is expected to expand at 8.1% CAGR from 2023 to 2032 owing to the presence of well-developed veterinary healthcare infrastructure in the region

Some of the top companies engaged in the veterinary molecular diagnostics market are IDEXX Laboratories Inc., Thermo Fischer Scientific Inc., bioMerieux SA, Qiagen, ID Vet, Biolab S.r.l., INDICAL BIOSCIENCE GmbH, Bionote USA Inc., Zoetis, Inc., and Neogen Corporation.

Veterinary Molecular Diagnostics Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 539
  • Countries covered: 19
  • Pages: 313
 Download Free Sample